Crossmark

A proteomic network approach across the <scp>ALS</scp> ‐ <scp>FTD</scp> disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain

Crossref DOI link: https://doi.org/10.15252/emmm.201708202

Published Online: 2017-11-30

Published Print: 2018-01

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Umoh, Mfon E

Dammer, Eric B

Dai, Jingting

Duong, Duc M

Lah, James J

Levey, Allan I

Gearing, Marla

Glass, Jonathan D https://orcid.org/0000-0002-3295-4971
Seyfried, Nicholas T https://orcid.org/0000-0002-4507-624X
Funding

Funding for this research was provided by:

Alzheimer's Association (11060)

Alzheimer’s Research UK (11060)

Michael J. Fox Foundation for Parkinson's Research (11060)

National Institute on Aging (U01AG046161‐02, P50AG025688, 5R01AG053960‐02)

National Institute of Neurological Disorders and Stroke (P30NS055077, 3T32NS007480‐16)
License Information

Version of Record valid from 2017-11-30
More Information

Publication History

Received: 2017-06-27

Accepted: 2017-10-20

Published: 2017-11-30

Document is current

Any future updates will be listed below